These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7996140)

  • 21. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    Stevenson PG; Hawke S; Bangham CR
    J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
    J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus.
    Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
    J Gen Virol; 2011 Sep; 92(Pt 9):2122-2132. PubMed ID: 21632569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.
    Duhaut SD; Dimmock NJ
    J Virol Methods; 2003 Mar; 108(1):75-82. PubMed ID: 12565156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein.
    Guo L; Zheng M; Ding Y; Li D; Yang Z; Wang H; Chen Q; Sui Z; Fang F; Chen Z
    Arch Virol; 2010 Nov; 155(11):1765-75. PubMed ID: 20652335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
    Wang X; Zhang W; Liu F; Zheng M; Zheng D; Zhang T; Yi Y; Ding Y; Luo J; Dai C; Wang H; Sun B; Chen Z
    Arch Virol; 2012 Aug; 157(8):1451-61. PubMed ID: 22552485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
    Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
    Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
    Furuya Y; Regner M; Lobigs M; Koskinen A; Müllbacher A; Alsharifi M
    J Gen Virol; 2010 Jun; 91(Pt 6):1450-60. PubMed ID: 20147516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective interfering influenza viruses and host cells: establishment and maintenance of persistent influenza virus infection in MDBK and HeLa cells.
    De BK; Nayak DP
    J Virol; 1980 Dec; 36(3):847-59. PubMed ID: 7463559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.
    Morgan DJ; Dimmock NJ
    J Virol; 1992 Feb; 66(2):1188-92. PubMed ID: 1731097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.